Product Code: ETC13156083 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Preventable Vaccines Market was valued at USD 48 Billion in 2024 and is expected to reach USD 67 Billion by 2031, growing at a compound annual growth rate of 4.40% during the forecast period (2025-2031).
The Global Preventable Vaccines Market is experiencing significant growth driven by increasing awareness about the importance of vaccination in preventing diseases. The market encompasses a wide range of vaccines aimed at preventing various infectious diseases such as measles, polio, influenza, and hepatitis. Factors such as government initiatives to promote vaccination programs, advancements in vaccine technology, and rising healthcare expenditure are contributing to the market`s expansion. Moreover, the ongoing COVID-19 pandemic has further highlighted the critical role of vaccines in public health. Key players in the market are focusing on research and development to introduce new and improved vaccines, while collaborations and partnerships are also common strategies to enhance market presence. The market is expected to continue growing as the global population seeks to protect themselves from preventable diseases through vaccination.
The Global Preventable Vaccines Market is experiencing significant growth driven by increasing awareness about the importance of vaccination, rising government initiatives to promote immunization, and the prevalence of infectious diseases worldwide. Technological advancements in vaccine development and production processes, along with the emergence of new vaccines targeting various diseases, are also contributing to market expansion. Opportunities in the market include the development of innovative vaccines for emerging infectious diseases, expansion into untapped regions with high disease burden, and collaborations between pharmaceutical companies and research institutions to enhance vaccine efficacy and accessibility. Additionally, the growing emphasis on preventive healthcare and the rising demand for affordable and effective vaccines in developing countries present promising prospects for market players to capitalize on.
The Global Preventable Vaccines Market faces challenges such as vaccine hesitancy leading to lower vaccination rates, especially in developed countries, which can hinder the market growth. High costs associated with research and development, manufacturing, and distribution of vaccines also pose a challenge in ensuring affordability and accessibility, particularly in emerging markets. Regulatory hurdles and stringent approval processes can delay the introduction of new vaccines into the market, limiting innovation and competition. Additionally, the logistical complexities of maintaining cold chains for storage and transportation of vaccines in remote or resource-constrained regions present operational challenges. Addressing these obstacles requires collaborative efforts among governments, healthcare organizations, and pharmaceutical companies to promote vaccination awareness, improve affordability, streamline regulatory processes, and enhance infrastructure for vaccine delivery.
The global preventable vaccines market is primarily driven by the increasing prevalence of infectious diseases and the rising awareness about the importance of vaccination in preventing these diseases. Government initiatives promoting immunization programs, advancements in vaccine technology leading to the development of new and improved vaccines, and the growing focus on preventive healthcare measures are also key drivers. Additionally, the expanding healthcare infrastructure in developing countries, the high demand for vaccines in emerging markets, and the growing investments by pharmaceutical companies in research and development activities to introduce novel vaccines further contribute to the market`s growth. The ongoing COVID-19 pandemic has also underscored the critical role of vaccines in safeguarding public health, driving a heightened emphasis on vaccination efforts worldwide.
Government policies related to the Global Preventable Vaccines Market aim to ensure widespread accessibility and affordability of vaccines to all populations, particularly in developing countries. Initiatives such as Gavi, the Vaccine Alliance, and the Global Vaccine Action Plan prioritize the distribution of vaccines to underserved communities and promote research and development of new vaccines. Governments also implement mandatory vaccination programs to protect public health and prevent the spread of infectious diseases. Additionally, regulatory bodies like the World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC) establish guidelines and standards for the production, distribution, and administration of vaccines to ensure safety and effectiveness. Overall, government policies play a crucial role in driving the growth and sustainability of the Global Preventable Vaccines Market.
The Global Preventable Vaccines Market is expected to witness significant growth in the coming years due to increased awareness about the importance of vaccination in preventing infectious diseases. The market is driven by factors such as government initiatives to promote vaccination programs, technological advancements in vaccine development, and the growing prevalence of vaccine-preventable diseases worldwide. The introduction of new vaccines targeting a wide range of diseases, along with the expansion of vaccination coverage in emerging economies, is projected to further boost market growth. Additionally, the ongoing COVID-19 pandemic has highlighted the critical role of vaccination in public health, leading to a heightened focus on vaccine research and development. Overall, the Global Preventable Vaccines Market is anticipated to experience steady expansion in the foreseeable future.
In the Global Preventable Vaccines Market, Asia is expected to witness the highest growth due to increasing government initiatives for immunization programs and rising awareness about preventive healthcare. North America holds a significant market share, driven by advanced healthcare infrastructure and high adoption rates of vaccines. Europe is also a key market, with a focus on research and development of new vaccines. Middle East and Africa are experiencing growth due to expanding immunization campaigns and improving healthcare facilities. Latin America is showing steady growth, supported by government initiatives to control infectious diseases. Overall, the market is expected to continue expanding globally as governments and organizations prioritize preventive healthcare measures to combat infectious diseases effectively.
Global Preventable Vaccines Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Preventable Vaccines Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Preventable Vaccines Market Revenues & Volume, 2021 & 2031F |
3.3 Global Preventable Vaccines Market - Industry Life Cycle |
3.4 Global Preventable Vaccines Market - Porter's Five Forces |
3.5 Global Preventable Vaccines Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Preventable Vaccines Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.7 Global Preventable Vaccines Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.8 Global Preventable Vaccines Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 Global Preventable Vaccines Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.10 Global Preventable Vaccines Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Global Preventable Vaccines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Preventable Vaccines Market Trends |
6 Global Preventable Vaccines Market, 2021 - 2031 |
6.1 Global Preventable Vaccines Market, Revenues & Volume, By Technology, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Preventable Vaccines Market, Revenues & Volume, By Inactivated Vaccines, 2021 - 2031 |
6.1.3 Global Preventable Vaccines Market, Revenues & Volume, By Live Attenuated Vaccines, 2021 - 2031 |
6.1.4 Global Preventable Vaccines Market, Revenues & Volume, By Toxoid Vaccines, 2021 - 2031 |
6.1.5 Global Preventable Vaccines Market, Revenues & Volume, By Others, 2021 - 2031 |
6.2 Global Preventable Vaccines Market, Revenues & Volume, By Indication, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Preventable Vaccines Market, Revenues & Volume, By Pneumococcal Disease, 2021 - 2031 |
6.2.3 Global Preventable Vaccines Market, Revenues & Volume, By Influenza, 2021 - 2031 |
6.2.4 Global Preventable Vaccines Market, Revenues & Volume, By Polio, 2021 - 2031 |
6.2.5 Global Preventable Vaccines Market, Revenues & Volume, By Hepatitis, 2021 - 2031 |
6.2.6 Global Preventable Vaccines Market, Revenues & Volume, By Others, 2021 - 2031 |
6.3 Global Preventable Vaccines Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Preventable Vaccines Market, Revenues & Volume, By Oral, 2021 - 2031 |
6.3.3 Global Preventable Vaccines Market, Revenues & Volume, By Parenteral, 2021 - 2031 |
6.4 Global Preventable Vaccines Market, Revenues & Volume, By End User, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Global Preventable Vaccines Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.4.3 Global Preventable Vaccines Market, Revenues & Volume, By Homecare, 2021 - 2031 |
6.4.4 Global Preventable Vaccines Market, Revenues & Volume, By Specialty Clinics, 2021 - 2031 |
6.4.5 Global Preventable Vaccines Market, Revenues & Volume, By Others, 2021 - 2031 |
6.5 Global Preventable Vaccines Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
6.5.1 Overview & Analysis |
6.5.2 Global Preventable Vaccines Market, Revenues & Volume, By Hospital Pharmacy, 2021 - 2031 |
6.5.3 Global Preventable Vaccines Market, Revenues & Volume, By Online Pharmacy, 2021 - 2031 |
6.5.4 Global Preventable Vaccines Market, Revenues & Volume, By Retail Pharmacy, 2021 - 2031 |
7 North America Preventable Vaccines Market, Overview & Analysis |
7.1 North America Preventable Vaccines Market Revenues & Volume, 2021 - 2031 |
7.2 North America Preventable Vaccines Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Preventable Vaccines Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Preventable Vaccines Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Preventable Vaccines Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Preventable Vaccines Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.4 North America Preventable Vaccines Market, Revenues & Volume, By Indication, 2021 - 2031 |
7.5 North America Preventable Vaccines Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.6 North America Preventable Vaccines Market, Revenues & Volume, By End User, 2021 - 2031 |
7.7 North America Preventable Vaccines Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
8 Latin America (LATAM) Preventable Vaccines Market, Overview & Analysis |
8.1 Latin America (LATAM) Preventable Vaccines Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Preventable Vaccines Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Preventable Vaccines Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Preventable Vaccines Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Preventable Vaccines Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Preventable Vaccines Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Preventable Vaccines Market, Revenues & Volume, By Technology, 2021 - 2031 |
8.4 Latin America (LATAM) Preventable Vaccines Market, Revenues & Volume, By Indication, 2021 - 2031 |
8.5 Latin America (LATAM) Preventable Vaccines Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
8.6 Latin America (LATAM) Preventable Vaccines Market, Revenues & Volume, By End User, 2021 - 2031 |
8.7 Latin America (LATAM) Preventable Vaccines Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
9 Asia Preventable Vaccines Market, Overview & Analysis |
9.1 Asia Preventable Vaccines Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Preventable Vaccines Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Preventable Vaccines Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Preventable Vaccines Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Preventable Vaccines Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Preventable Vaccines Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Preventable Vaccines Market, Revenues & Volume, By Technology, 2021 - 2031 |
9.4 Asia Preventable Vaccines Market, Revenues & Volume, By Indication, 2021 - 2031 |
9.5 Asia Preventable Vaccines Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
9.6 Asia Preventable Vaccines Market, Revenues & Volume, By End User, 2021 - 2031 |
9.7 Asia Preventable Vaccines Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
10 Africa Preventable Vaccines Market, Overview & Analysis |
10.1 Africa Preventable Vaccines Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Preventable Vaccines Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Preventable Vaccines Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Preventable Vaccines Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Preventable Vaccines Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Preventable Vaccines Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Preventable Vaccines Market, Revenues & Volume, By Technology, 2021 - 2031 |
10.4 Africa Preventable Vaccines Market, Revenues & Volume, By Indication, 2021 - 2031 |
10.5 Africa Preventable Vaccines Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
10.6 Africa Preventable Vaccines Market, Revenues & Volume, By End User, 2021 - 2031 |
10.7 Africa Preventable Vaccines Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
11 Europe Preventable Vaccines Market, Overview & Analysis |
11.1 Europe Preventable Vaccines Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Preventable Vaccines Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Preventable Vaccines Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Preventable Vaccines Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Preventable Vaccines Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Preventable Vaccines Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Preventable Vaccines Market, Revenues & Volume, By Technology, 2021 - 2031 |
11.4 Europe Preventable Vaccines Market, Revenues & Volume, By Indication, 2021 - 2031 |
11.5 Europe Preventable Vaccines Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
11.6 Europe Preventable Vaccines Market, Revenues & Volume, By End User, 2021 - 2031 |
11.7 Europe Preventable Vaccines Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
12 Middle East Preventable Vaccines Market, Overview & Analysis |
12.1 Middle East Preventable Vaccines Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Preventable Vaccines Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Preventable Vaccines Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Preventable Vaccines Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Preventable Vaccines Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Preventable Vaccines Market, Revenues & Volume, By Technology, 2021 - 2031 |
12.4 Middle East Preventable Vaccines Market, Revenues & Volume, By Indication, 2021 - 2031 |
12.5 Middle East Preventable Vaccines Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
12.6 Middle East Preventable Vaccines Market, Revenues & Volume, By End User, 2021 - 2031 |
12.7 Middle East Preventable Vaccines Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
13 Global Preventable Vaccines Market Key Performance Indicators |
14 Global Preventable Vaccines Market - Export/Import By Countries Assessment |
15 Global Preventable Vaccines Market - Opportunity Assessment |
15.1 Global Preventable Vaccines Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Preventable Vaccines Market Opportunity Assessment, By Technology, 2021 & 2031F |
15.3 Global Preventable Vaccines Market Opportunity Assessment, By Indication, 2021 & 2031F |
15.4 Global Preventable Vaccines Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
15.5 Global Preventable Vaccines Market Opportunity Assessment, By End User, 2021 & 2031F |
15.6 Global Preventable Vaccines Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
16 Global Preventable Vaccines Market - Competitive Landscape |
16.1 Global Preventable Vaccines Market Revenue Share, By Companies, 2024 |
16.2 Global Preventable Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |